PT-141 (Bremelanotide) is the free-acid C-terminal cyclic lactam metabolite of Melanotan II, investigated as a centrally acting MC4R/MC3R agonist in hypothalamic neuroendocrine signaling models.
Scientific Profile & Research Key Points: PT-141
PT-141 (Bremelanotide) is the free-acid C-terminal cyclic lactam metabolite of Melanotan II, investigated as a centrally acting MC4R/MC3R agonist in hypothalamic neuroendocrine signaling models.
Active Batch Release Specifications (Lot SL-2026-151)
Analytical release verification for current PT-141 (10 mg) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-151 | 2026-10-28 | RP-HPLC (C18, 214nm) + ESI-MS | ≥99.0% (Single Peak) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL)
Temperature & Stability
Store lyophilized at -20°C shielded from light; refrigerate solution at 2°C–8°C for up to 28 days.
PT-141 — Technical Questions & Answers
What is the molar concentration when reconstituting PT-141 (10 mg) in 2.0 mL?
Reconstituting the full 10 mg vial of PT-141 (MW 1025.16 g/mol) in 2.0 mL of diluent produces a 5.00 mg/mL stock solution — equivalent to approximately 4.88 mM (4,877 µM) gross molarity before Net Peptide Content (NPC) adjustment.
How does PT-141's counterion stoichiometry affect assay mass calculations?
PT-141 (CAS 189691-06-3, formula C50H68N14O10) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.
Which analytical methods verify PT-141 Lot SL-2026-151 and what pathway does it target?
Lot SL-2026-151 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 1025.16 g/mol. In preclinical literature, PT-141 targets Central Melanocortin-4 (MC4R) & MC3R Receptors (Molinoff P.B. et al., Ann N Y Acad Sci (2003) — PT-141 melanocortin receptor neuropharmacology (PMID: 12851299)).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
PT-141 (Bremelanotide): Cyclic Peptide Structure, Central Melanocortin Pathways, and Receptor Kinetics
A deep analysis of Bremelanotide (PT-141), the active metabolite of Melanotan II. Central MC3R/MC4R agonism, hypothalamic signaling, and analytical HPLC characterization.
How to Read a Peptide Certificate of Analysis (COA): Step-by-Step Breakdown
A practical guide for researchers. How to analyze HPLC chromatograms, verify retention time, interpret mass spec m/z peaks, evaluate counterion salt ratios, and spot fraudulent documents.
How to Reconstitute Research Peptides: Complete Laboratory Protocol and Best Practices
Standard Operating Procedure (SOP) for peptide reconstitution. Diluent selection (BAC water vs acetic acid), meniscus calculations, avoiding foaming, and cold storage parameters.